Cargando…
Survival, response and immune effects in a prospectively randomized study of dose strategy for alpha-N1 interferon.
Several tumour sites have now demonstrated objective responses to alpha interferons in a diversity of doses and schedules. Since effectiveness should be enhanced with the identification of an optimal dose strategy, we undertook a prospectively randomized study to compare an intermittent high dose es...
Autores principales: | Silver, H. K., Connors, J. M., Kong, S., Karim, K. A., Spinelli, J. J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1988
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246878/ https://www.ncbi.nlm.nih.gov/pubmed/2975951 |
Ejemplares similares
-
Similar biological effects of different low doses of interferon alpha in cancer patients.
por: Billard, C., et al.
Publicado: (1987) -
Interferon-alpha, immune activation and immune dysfunction in treated HIV infection
por: Cha, Lilian, et al.
Publicado: (2014) -
Dose efficacy study of two schedules of high-dose bolus administration of interleukin 2 and interferon alpha in metastatic melanoma.
por: Kruit, W. H., et al.
Publicado: (1996) -
Recombinant alpha 2 interferon is superior to doxorubicin for inoperable hepatocellular carcinoma: a prospective randomised trial.
por: Lai, C. L., et al.
Publicado: (1989) -
New Perspectives of Interferon-alpha2 and Inflammation in Treating Philadelphia-negative Chronic Myeloproliferative Neoplasms
por: Hasselbalch, Hans C., et al.
Publicado: (2021)